HSV-1 and Alzheimer's disease: More than a hypothesis

Roberto Piacentini, Giovanna De Chiara, D. Li Puma Domenica, Cristian Ripoli, Maria E. Marcocci, Enrico Garaci, Anna T. Palamara, Claudio Grassi

Research output: Contribution to journalArticlepeer-review


Among the multiple factors concurring to Alzheimer's disease (AD) pathogenesis, greater attention should be devoted to the role played by infectious agents. Growing epidemiological and experimental evidence suggests that recurrent herpes simplex virus type-1 (HSV-1) infection is a risk factor for AD although the underlying molecular and functional mechanisms have not been fully elucidated yet. Here, we review literature suggesting the involvement of HSV-1 infection in AD also briefly mentioning possible pharmacological implications of these findings.

Original languageEnglish
Article number97
JournalFrontiers in Pharmacology
Volume5 MAY
Publication statusPublished - 2014


  • Alzheimer's disease
  • Amyloid-β protein
  • HSV-1
  • Recurrent infection
  • γ secretase

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'HSV-1 and Alzheimer's disease: More than a hypothesis'. Together they form a unique fingerprint.

Cite this